D.E. Shaw & Co
OYST

D.E. Shaw & Co’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

D.E. Shaw & Co’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,137
Closed -$320K – 4235
2020
Q3 		$320K Sell
15,137
-27,918
-65% -$653K ﹤0.01% 3419
2020
Q2 		$1.24M Buy
+43,055
New +$1.3M ﹤0.01% 2778

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

D.E. Shaw & Co's OYST Position: Q4 2020 in Review

D.E. Shaw & Co sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2020, closing a stake of 15,137 shares — an estimated $320K sold.

D.E. Shaw & Co first reported a position in OYST in Q2 2020 and held it in 2 quarters. The position peaked at $1.24M in Q2 2020. 60 funds tracked by Wall St. Rank hold OYST as of Q4 2020.

  • D.E. Shaw & Co reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 15,137 Oyster Point Pharma, Inc. Common Stock shares in Q4 2020, an estimated $320K.
  • D.E. Shaw & Co first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • D.E. Shaw & Co's Oyster Point Pharma, Inc. Common Stock position peaked at $1.24M in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2020.

Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.